High enrollment cycle time variance is a term used to describe an enrollment process that does not perform consistently relative to enrollment plans. This variability results in missed schedule milestones, over- or under-budgeting of trials and workforce, and the perception that the planning process is flawed. This webinar will examine the root causes of our inability to control enrollment cycle time variability and deadline delays and why better planning and site selection cannot address them.
Organized by:
Drug Information Association
Invited Speakers:
Peter H. Blake, PhD President Precis Trial LLC United States
Jeffrey J. DiFrancesco, MS, MSc Asst. Prof. of Pharmaceutical & Healthcare Business, College of Graduate Studies University of the Sciences in Philadelphia United States.